Anika Therapeutics (ANIK) Return on Capital Employed Growth (3y) (2014 - 2026)
Anika Therapeutics (ANIK) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 1,036.00 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 175.00 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 120.00 |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 434.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -295.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 1,076.00 |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 1,898.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn | -142.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -142.00 |
| Mar 31, 2026 | -579.00 |
| Dec 31, 2025 | -773.00 |
| Sep 30, 2025 | -58.00 |
| Jun 30, 2025 | -71.00 |
| Mar 31, 2025 | -316.00 |
| Dec 31, 2024 | -345.00 |
| Sep 30, 2024 | 1,105.00 |
| Jun 30, 2024 | 1,017.00 |
| Mar 31, 2024 | 1,534.00 |
| Dec 31, 2023 | 831.00 |
| Sep 30, 2023 | -108.00 |
| Jun 30, 2023 | -547.00 |
| Mar 31, 2023 | -1,228.00 |
| Dec 31, 2022 | -994.00 |
| Sep 30, 2022 | -2,015.00 |
| Jun 30, 2022 | -1,710.00 |
| Mar 31, 2022 | -1,316.00 |
| Dec 31, 2021 | -746.00 |
| Sep 30, 2021 | -1,030.00 |